A patient with Sickle Cell Anemia is showing signs of acute chest syndrome and potential sepsis. As the primary nurse, what is the most appropriate initial intervention to stabilize the patient?

A) Administer high-flow oxygen via non-rebreather mask.

B) Prepare the patient for immediate exchange transfusion therapy.

C) Initiate broad-spectrum antibiotics as per standing orders.

D) Increase intravenous fluid rate to treat hypotension.

A patient with Sickle Cell Anemia presents with acute chest syndrome and potential sepsis. Despite receiving oxygen via a non-rebreather mask, her oxygen saturation remains at 82%. Which of the following nursing interventions is the highest priority to stabilize the patient's condition?

A) Initiate high-flow nasal cannula oxygen therapy to improve oxygenation.

D) Increase intravenous fluid administration to manage hypovolemic shock.

A 25-year-old female with Sickle Cell Anemia has developed an ischemic stroke affecting the left hemisphere after undergoing an exchange transfusion. She exhibits acute neurological changes and signs of an inflammatory response. As the nurse coordinating her care, what is the most critical priority to address initially?

B) Initiate neuroprotective strategies and consult neurology for stroke management.

A) Administer thrombolytic therapy immediately to resolve the ischemic stroke.

B) Initiate neuroprotective strategies and consult neurology for stroke management.

C) Focus on treating the potential infectious process with targeted antibiotics.

D) Intensify respiratory support to prevent complications from acute chest syndrome.

A nurse is caring for a 16-year-old patient with Sickle Cell Anemia who has recently undergone an exchange transfusion and now presents with signs of an ischemic stroke. Given the current clinical status, which is the highest priority nursing intervention to prevent further neurological deterioration?

D) Optimize oxygenation by administering supplemental oxygen and monitoring respiratory status.

A) Administer prescribed analgesics to manage pain and reduce stress.

B) Maintain adequate hydration to prevent further sickling of red blood cells.

C) Initiate thrombolytic therapy as prescribed to dissolve the existing clot.

D) Optimize oxygenation by administering supplemental oxygen and monitoring respiratory status.

A patient with Sickle Cell Anemia has developed Acute Chest Syndrome (ACS) and is currently on a non-rebreather mask due to low oxygen saturation. Which of the following interventions should the nurse prioritize to prevent further respiratory compromise?

D) Implement incentive spirometry to promote lung expansion.

A) Administer intravenous fluids aggressively to improve circulation.

B) Initiate high-flow nasal cannula to increase oxygen delivery.

C) Prepare for possible intubation and mechanical ventilation.

D) Implement incentive spirometry to promote lung expansion.

A patient with Sickle Cell Anemia has developed Acute Chest Syndrome (ACS) with a respiratory rate of 28 breaths per minute, oxygen saturation of 88% on room air, bilateral crackles, diminished breath sounds, and diffuse pulmonary infiltrates on chest X-ray. After escalating oxygen therapy and reviewing the antibiotic regimen, which of the following nursing actions is most critical to prioritize next?

A) Administering corticosteroids to reduce pulmonary inflammation.

B) Initiating a fluid bolus to address potential dehydration.

C) Preparing for immediate endotracheal intubation and mechanical ventilation.

D) Monitoring neurological status for potential changes due to recent ischemic stroke.

A patient with sickle cell disease presents with Acute Chest Syndrome and a marked increase in white blood cell count. The healthcare team is considering an exchange transfusion. As the nurse, what is the priority assessment in evaluating the effectiveness of this intervention?

B) Assessing the patient's respiratory rate and oxygen saturation

A) Monitoring the patient's hemoglobin and hematocrit levels

B) Assessing the patient's respiratory rate and oxygen saturation

C) Evaluating the patient's pain level and analgesic requirements

D) Checking the patient's urine output and renal function

A 25-year-old female with a history of sickle cell disease is admitted with Acute Chest Syndrome. Her laboratory tests reveal increased white blood cell count, decreased hemoglobin level, and elevated inflammatory markers. After initiating broad-spectrum antibiotics and considering an exchange transfusion, her condition remains critical. Which nursing intervention is the priority to prevent further complications?

B) Collaborate with the respiratory therapist to optimize her ventilatory support settings.

A) Initiate continuous renal replacement therapy to prevent acute renal failure.

B) Collaborate with the respiratory therapist to optimize her ventilatory support settings.

C) Administer additional boluses of intravenous fluids to improve circulation and oxygen delivery.

D) Prepare for emergent intubation to secure the airway and provide mechanical ventilation.

A 28-year-old female with a history of sickle cell disease presents with acute kidney injury and hyperkalemia, as evidenced by a serum creatinine level of 2.3 mg/dL, BUN of 45 mg/dL, and potassium level of 5.6 mEq/L. The healthcare team is considering initiating continuous renal replacement therapy (CRRT) due to her hemodynamic instability. As the nurse on the interdisciplinary team, which intervention would be the most appropriate to prioritize in managing this patient’s condition while awaiting nephrology consultation?

A) Administer calcium gluconate to stabilize the cardiac membrane and prevent arrhythmias due to hyperkalemia.

B) Initiate intravenous fluids aggressively to rapidly correct her hypovolemic state and enhance renal perfusion.

C) Withhold all medications to prevent further renal insult until the nephrology consultation is complete.

D) Begin oral sodium polystyrene sulfonate to bind potassium and lower serum levels immediately.

A patient with a sickle cell crisis has developed acute kidney injury (AKI) with a serum creatinine level of 2.3 mg/dL and potassium level of 5.6 mEq/L. The healthcare team is considering continuous renal replacement therapy (CRRT). Which nursing action is most critical to prioritize for this patient at this time?

C) Monitor and document the patient's urinary output and vital signs closely.

A) Administer a potassium-binding resin to reduce serum potassium levels.

B) Initiate a low-potassium diet to prevent further hyperkalemia.

C) Monitor and document the patient's urinary output and vital signs closely.

D) Prepare the patient for immediate hemodialysis to rapidly correct electrolyte imbalances.

Sickle Cell Anemia - Nursing Case Study

Pathophysiology

• Primary mechanism: Sickle Cell Anemia arises from a mutation in the HBB gene, causing hemoglobin S (HbS) production. Under low oxygen conditions, HbS polymerizes, distorting red blood cells into a sickle shape, leading to impaired flexibility and increased fragility.

• Secondary mechanism: The sickled cells obstruct microvasculature, causing vaso-occlusive crises. This blockage results in ischemia and severe pain due to tissue hypoxia and potential organ damage, particularly affecting the spleen, lungs, and brain.

• Key complication: Chronic hemolysis of sickled cells reduces red blood cell lifespan, leading to chronic anemia, and contributes to hyperbilirubinemia, increasing the risk of gallstones and further organ damage, exacerbating complications like acute chest syndrome or stroke.

Patient Profile

Demographics:

24-year-old female, college student

History:

• Key past medical history: Diagnosed with Sickle Cell Anemia at age 2, history of acute chest syndrome, avascular necrosis of the hip, and frequent vaso-occlusive crises

• Current medications: Hydroxyurea, folic acid, L-glutamine, ibuprofen as needed for pain, monthly blood transfusions

• Allergies: Penicillin (causes rash)

Current Presentation:

• Chief complaint: Severe generalized pain and difficulty breathing

• Key symptoms: Intense pain in back and limbs, shortness of breath, fatigue, dizziness, jaundice

• Vital signs: Temperature: 102.4°F (39.1°C), Heart Rate: 130 bpm, Respiratory Rate: 28 breaths per minute, Blood Pressure: 90/60 mmHg, Oxygen Saturation: 86% on room air

Section 1

Change in Patient Status:

Shortly after admission, the patient's condition deteriorates, prompting immediate reassessment by the healthcare team. Her oxygen saturation drops further to 82% despite administration of supplemental oxygen via a non-rebreather mask. She becomes increasingly lethargic and confused, exhibiting new-onset disorientation. Her skin appears more jaundiced, with pronounced scleral icterus, and her respiratory effort becomes labored, with audible wheezing and crackles heard upon auscultation of the lung fields. Her heart rate remains elevated at 140 bpm, and her blood pressure further declines to 85/55 mmHg, suggesting impending shock.

Laboratory tests reveal a hemoglobin level of 6.5 g/dL, a significant drop from her baseline, with a reticulocyte count markedly elevated at 12%, indicating a hyperproliferative response to her severe anemia. Her white blood cell count is elevated at 18,000/mm³, suggestive of an inflammatory or infectious process, while her bilirubin level is critically high at 5.2 mg/dL, consistent with ongoing hemolysis. Chest X-ray shows diffuse infiltrates, raising concern for acute chest syndrome, a severe complication of Sickle Cell Anemia that requires urgent intervention.

This change in status necessitates a shift in clinical priorities, focusing on aggressive management of her acute chest syndrome and potential sepsis. The medical team must implement advanced interventions, including intensive monitoring, possible initiation of exchange transfusion therapy to rapidly decrease the proportion of sickled cells, and broad-spectrum antibiotics to address the potential infectious component. The complexity of her condition underscores the need for precise clinical judgment and coordination across multidisciplinary teams to stabilize her and prevent further complications.

Section 2

As the medical team initiates aggressive management, the patient undergoes an exchange transfusion to reduce the percentage of sickled cells. Despite initial stabilization, her condition again takes a concerning turn. After the procedure, she exhibits signs of acute neurological changes, including difficulty speaking coherently and a noticeable right-sided facial droop. The rapid neurologic assessment reveals asymmetrical reflexes and reduced strength in her right arm, raising the alarm for a potential cerebrovascular accident (CVA), a known complication in patients with Sickle Cell Anemia due to vaso-occlusion.

In response, the healthcare team performs an urgent brain MRI, which confirms the presence of an ischemic stroke affecting the left hemisphere, specifically in the middle cerebral artery territory. Concurrently, laboratory results show an escalation in inflammatory markers, with a C-reactive protein level climbing to 12 mg/dL and a further increase in white blood cell count to 22,000/mm³. These findings suggest a heightened inflammatory state, possibly exacerbated by an infectious process, despite the initiation of broad-spectrum antibiotics.

The complexity of her clinical picture requires a rapid reassessment of priorities. The focus shifts towards neuroprotective strategies and continued management of acute chest syndrome while addressing the potential infection source. Neurology is consulted for stroke management, considering the risks and benefits of thrombolytic therapy in the context of her recent exchange transfusion and ongoing hemolytic crisis. The multidisciplinary team convenes to refine her care plan, emphasizing the need for vigilant monitoring of her neurological status and respiratory function, ensuring her condition does not spiral into further complications.

Section 3

As the healthcare team continues to manage the multifaceted challenges presented by the patient’s condition, a new complication emerges. Despite aggressive treatment and close monitoring, the patient begins to exhibit signs of Acute Chest Syndrome (ACS), a life-threatening complication in Sickle Cell Anemia. Her respiratory rate increases to 28 breaths per minute, accompanied by a drop in oxygen saturation to 88% on room air. Auscultation of the lungs reveals bilateral crackles, with diminished breath sounds at the bases. Her chest X-ray confirms diffuse pulmonary infiltrates, indicative of ACS progression. The patient's blood pressure reads 135/90 mmHg, her heart rate escalates to 112 beats per minute, and she develops a low-grade fever of 101°F, all of which suggest a worsening systemic inflammatory response.

In response to these alarming developments, the medical team prioritizes interventions to stabilize her respiratory function. The patient is promptly placed on supplemental oxygen, initially via nasal cannula, but her oxygen saturation remains suboptimal, necessitating an escalation to a non-rebreather mask. Concurrently, the team increases her fluid intake cautiously to counteract dehydration without exacerbating pulmonary edema. Given the potential for infection to trigger or worsen ACS, a review of her antibiotic regimen is undertaken to ensure broad-spectrum coverage is adequate and to identify any need for adjustment based on recent cultures.

The patient's condition is precariously balanced, requiring an intricate balance of therapies. Steroids are introduced to help reduce pulmonary inflammation, while close monitoring of her neurological status continues, given the recent ischemic stroke. The complex interplay of her symptoms necessitates ongoing collaboration among specialists in hematology, pulmonology, and neurology, as they work to refine her treatment plan. The multidisciplinary team remains vigilant for any further signs of deterioration, recognizing the potential for rapid escalation of her condition. As they navigate these challenges, they also prepare for the possibility of more invasive interventions, such as mechanical ventilation, should her respiratory status decline further.

Section 4

As the team continues to manage the patient's acute condition, new diagnostic results reveal a concerning development. Laboratory tests show a marked increase in white blood cell count to 18,000/mm³, indicating a potential infectious process that could be exacerbating her Acute Chest Syndrome. Her hemoglobin level has dropped to 7.5 g/dL, suggesting ongoing hemolysis or possible sequestration. Blood cultures are pending, but preliminary urinalysis results suggest the presence of a urinary tract infection, a common infectious trigger in sickle cell crises. Inflammatory markers, including C-reactive protein and erythrocyte sedimentation rate, are significantly elevated, corroborating the systemic inflammatory response already suspected.

These findings prompt the healthcare team to adjust the patient's antibiotic regimen to ensure it is sufficiently comprehensive to cover both gram-positive and gram-negative organisms, as well as atypical pathogens that might contribute to her worsening respiratory status. The hematology team considers an exchange transfusion to reduce the proportion of sickled cells and improve oxygen delivery, while also weighing the risks and benefits given her current instability. The pulmonology team assesses the need for more advanced respiratory support, possibly transitioning to high-flow nasal cannula or non-invasive positive pressure ventilation, to better manage her increasing work of breathing and maintain adequate oxygenation.

Despite these interventions, the patient's condition remains fragile, with an increased risk for further complications such as acute renal failure or multi-organ dysfunction syndrome. The critical care team remains on high alert, implementing continuous monitoring of her vital signs and organ function. They prepare to escalate her care promptly should there be any indication of further deterioration. This careful orchestration of medical interventions underscores the complexity of managing severe sickle cell complications and highlights the necessity for precise clinical judgment and interdisciplinary collaboration in optimizing patient outcomes.

Section 5

New diagnostic results reveal a further complication as the patient's renal function deteriorates. Her serum creatinine level has risen to 2.3 mg/dL from a baseline of 0.9 mg/dL, and her blood urea nitrogen (BUN) has increased to 45 mg/dL, indicating acute kidney injury likely exacerbated by the ongoing systemic inflammatory response and hemolysis. Additionally, her potassium level has increased to 5.6 mEq/L, raising concerns about hyperkalemia, which could precipitate cardiac arrhythmias. These findings necessitate immediate nephrology consultation to assess the possibility of initiating renal replacement therapy if her condition worsens.

In response to these alarming renal findings, the healthcare team refines their therapeutic approach. Fluid management becomes a critical focus; they aim to maintain her euvolemic state while being cautious of fluid overload, given her respiratory compromise. Diuretics are considered to promote renal clearance and manage her electrolyte imbalance, but careful monitoring is required to avoid exacerbating her hypovolemic state. The potential need for renal replacement therapy looms, and preparations for continuous renal replacement therapy (CRRT) are made, given its suitability for hemodynamically unstable patients.

This new renal complication underscores the precarious balance between various organ systems in the context of sickle cell crisis management. The team must now navigate these overlapping challenges, employing rigorous clinical reasoning to prioritize interventions that stabilize her renal function while continuing to address her respiratory status and infection control. The interdisciplinary team remains vigilant, ready to adapt their strategy as new data emerges, understanding that the path to recovery involves a delicate interplay of aggressive yet measured interventions.